Molecule Structure

Scientific Name

Meloxicam

Description of the Drug

Meloxicam is an NSAID used to treat osteoarthritis in adults, rheumatoid arthritis in adults, and juvenile rheumatoid arthritis in pediatrics.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00814

Brand Name(s)

Anjeso, Meloxicam, Mobic, Qmiiz odt, Vivlodex

Company Owner(s)

Cipla Ltd, Iceutica Operations Llc, Sun Pharmaceutical Industries Inc, Tersera Therapeutics Llc, Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Novitium Pharma Llc, Boehringer Ingelheim Pharmaceuticals Inc, Anda Repository Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cyclooxygenase-2 SINGLE PROTEIN INHIBITOR CHEMBL230

Unichem Links

Atlas meloxicam
SureChEMBL SCHEMBL3576 SCHEMBL23589638
Human Metabolome Database HMDB0014952
DrugBank DB00814
PubChem: Thomson Pharma 14754262
PubChem 54677470
Mcule MCULE-4138373089
NMRShiftDB 60027946
Nikkaji J22.773K
PDBe MXM
BindingDB 50056998
EPA CompTox Dashboard DTXSID1020803
DrugCentral 1676
Metabolights MTBLC6741
Brenda 5320 74731
ChemicalBook CB2191355
Guide to Pharmacology 7220
rxnorm MELOXIDYL MOBIC VIVLODEX LOXICOM METACAM ANJESO MELOXICAM
PubChem: Drugs of the Future 12013466
KEGG Ligand C08169
ChEBI 6741
ZINC ZINC000013129998